⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)

Official Title: A Multicenter, NI, Retrospective, Observational Study Evaluating Real-World Treatment Outcomes in Japanese Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Avelumab Plus Axitinib as First-line Therapy: J-DART2

Study ID: NCT05650164

Interventions

avelumab
axitinib

Study Description

Brief Summary: This study is a multicenter, non-interventional, retrospective, medical chart review of patients with metastatic renal cell cancer(mRCC) treated with avelumab plus axitinib as a first-line therapy in Japan between 20 December 2019 and 17 October 2022. All decisions regarding clinical management and treatment of the participating patients were made by the investigator as part of standard care in real-world clinical setting and were not contingent upon the patient's participation in the study. Data will be collected if available per study site.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Nagoya University Hospital, Nagoya, Aichi, Japan

Hirosaki University Hospital, Hirosaki, Aomori, Japan

Kurume University Hospital, Kurume-shi, Fukuoka, Japan

Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan

Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan

Kobe City Medical Center General Hospital, Kobe-city, Hyogo, Japan

Kobe University Hospital, Kobe, Hyogo, Japan

Kanazawa University Hospital, Kanazawa-shi, Ishikawa, Japan

National Hospital Organization Kyoto Medical Center, Kyoto-shi, Kyoto, Japan

Kochi Medical School Hospital, Nankoku, Kōchi, Japan

Kindai University Hospital, Osakasayama, Osaka, Japan

Osaka University Hospital, Suita-city, Osaka, Japan

Jichi Medical University Saitama Medical Center, Saitama City, Saitama, Japan

Keio University Hospital, Shinjuku-ku, Tokyo, Japan

Wakayama Medical University Hospital, Wakayama-shi, Wakayama, Japan

Yamagata University Hospital, Yamagata-Shi, Yamagata, Japan

Kyushu University Hospital, Fukuoka, , Japan

Hiroshima University Hospital, Hiroshima, , Japan

University Hospital Kyoto Prefectural University of Medicine, Kyoto, , Japan

Contact Details

Name: Medical Responsible

Affiliation: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: